PlainPharmaWatch

CMS Open Payments · Tool

Immunocore Limited vs Roche Diagnostics Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Immunocore Limited has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,543, versus 407 for the other company. Its single largest recorded recipient represents 43.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Immunocore Limited
HHI 3,543 · top recipient 43.6%
Ranked #498 of 1,838 companies by HHI
Roche Diagnostics Corporation
HHI 407 · top recipient 17.8%
Ranked #1,370 of 1,838 companies by HHI

Payment Overview

Company A

Immunocore Limited

Total Payments
$2.0M
% of Industry
0.0%
Transactions
1,246
Avg per Transaction
$1.6K
Recipients
1,028
Avg per Recipient
$2.0K
Payment Types
6
Top Payment Type
Consulting Fee
Total Payments
$2.0M
% of Industry
0.0%
Transactions
928
Avg per Transaction
$2.2K
Recipients
900
Avg per Recipient
$2.2K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Immunocore Limited vs Roche Diagnostics Corporation - total reported payments in CMS Open Payments PY2024

Immunocore Limited$2.0MRoche Diagnostics Corporati…$2.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Immunocore Limited

Consulting Fee $552.2K

48.4%

Honoraria $498.1K

43.7%

Travel and Lodging $45.5K

4.0%

Food and Beverage $27.9K

2.4%

Space Rental or Facility Fees $16.8K

1.5%

Education $30.00

0.0%

Roche Diagnostics Corporation

Consulting Fee $373.3K

67.5%

Compensation for Services Other Than Consulting $97.4K

17.6%

Food and Beverage $41.1K

7.4%

Travel and Lodging $40.9K

7.4%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Immunocore Limited

  1. 1

    ROY HERBST

    $496,768.31 · 54 txns

  2. 2

    SUSHAMA SCALERA

    $461,416.59 · 13 txns

  3. 3

    Sajeve Thomas

    $12,971.72 · 19 txns

  4. 4

    Yana Najjar

    $11,489.37 · 14 txns

  5. 5

    KATHERINE WANG

    $10,959.70 · 19 txns

Roche Diagnostics Corporation

  1. 1

    ROBERT R REDFIELD JR.

    $98,387.00 · 6 txns

  2. 2

    ANTHONY M MAGLIOCCO

    $14,312.62 · 9 txns

  3. 3

    BRIAN J CAVENEY

    $12,543.53 · 23 txns

  4. 4

    GIOVANNI M LUJAN

    $11,771.01 · 6 txns

  5. 5

    DAVID S MCCLINTOCK

    $11,686.56 · 10 txns

Summary Comparison

Metric Immunocore Limited Roche Diagnostics Corporation
Total Payments $2.0M $2.0M
% of Industry Total 0.0% 0.0%
Transaction Count 1,246 928
Avg per Transaction $1.6K $2.2K
Recipient Count 1,028 900
Avg per Recipient $2.0K $2.2K
Payment Type Count 6 4
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.